Salt Lake City, UT, United States of America

Lisa Abegglen

This inventor holds 2 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignees: Technion Research & Development Foundation Ltd, University of Utah Research Foundation. Active years: 2020-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lisa Abegglen. Retrieved from https://idiyas.com/inventor/lisa-abegglen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0


 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2020-2023

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Lisa Abegglen: Innovator in Cancer Research

Introduction

Lisa Abegglen is a prominent inventor based in Salt Lake City, UT (US). She has made significant contributions to the field of cancer research, focusing on innovative methods and compositions for cancer treatment. With a total of 2 patents, her work is paving the way for new therapeutic approaches.

Latest Patents

Abegglen's latest patents include groundbreaking methods and compositions for preventing or treating cancer. The present disclosure is directed to methods and compositions for inhibiting a cancer cell using nucleic acid sequences encoding elephant p53 or elephant p53 amino acid sequences. This innovative approach highlights her commitment to advancing cancer treatment.

Career Highlights

Throughout her career, Lisa has worked with esteemed organizations such as the University of Utah Research Foundation and Technion Research & Development Foundation Ltd. Her experience in these institutions has allowed her to collaborate with leading experts in the field.

Collaborations

Some of her notable coworkers include Joshua Schiffman and Avi Schroeder. Their collaborative efforts have contributed to the advancement of cancer research and the development of new treatment methodologies.

Conclusion

Lisa Abegglen's innovative work in cancer research exemplifies her dedication to improving treatment options for patients. Her patents and collaborations reflect her significant impact on the scientific community.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…